Preferred Reporting Items for a Systematic Review and Meta-analysis of Individual Participant Data The PRISMA-IPD Statement

被引:1505
|
作者
Stewart, Lesley A. [1 ]
Clarke, Mike [2 ]
Rovers, Maroeska [3 ]
Riley, Richard D. [4 ,5 ]
Simmonds, Mark [1 ]
Stewart, Gavin [1 ,6 ]
Tierney, Jayne F. [7 ]
机构
[1] Univ York, Ctr Reviews & Disseminat, York YO10 5DD, N Yorkshire, England
[2] Queens Univ Belfast, All Ireland Hub Trials Methodol Res, Belfast, Antrim, North Ireland
[3] Radboudumc, Radbound Inst Hlth Sci, Nijmegen, Netherlands
[4] Keele Univ, Res Inst Primary Care & Hlth Sci, Keele ST5 5BG, Staffs, England
[5] Univ Birmingham, Sch Hlth & Populat Sci, Birmingham, W Midlands, England
[6] Newcastle Univ, Ctr Rural Econ, Sch Agr Food & Rural Dev, Newcastle Upon Tyne, Tyne & Wear, England
[7] UCL, MRC Clin Trials Unit, London, England
来源
JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION | 2015年 / 313卷 / 16期
关键词
PATIENT DATA; PREDICTION MODELS; RISK; MORTALITY; OUTCOMES; TRIALS;
D O I
10.1001/jama.2015.3656
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
IMPORTANCE Systematic reviews and meta-analyses of individual participant data (IPD) aim to collect, check, and reanalyze individual-level data from all studies addressing a particular research question and are therefore considered a gold standard approach to evidence synthesis. They are likely to be used with increasing frequency as current initiatives to share clinical trial data gain momentum and may be particularly important in reviewing controversial therapeutic areas. OBJECTIVE To develop PRISMA-IPD as a stand-alone extension to the PRISMA (Preferred Reporting Items for Systematic Reviews and Meta-Analyses) Statement, tailored to the specific requirements of reporting systematic reviews and meta-analyses of IPD. Although developed primarily for reviews of randomized trials, many items will apply in other contexts, including reviews of diagnosis and prognosis. DESIGN Development of PRISMA-IPD followed the EQUATOR Network framework guidance and used the existing standard PRISMA Statement as a starting point to draft additional relevant material. A web-based survey informed discussion at an international workshop that included researchers, clinicians, methodologists experienced in conducting systematic reviews and meta-analyses of IPD, and journal editors. The statement was drafted and iterative refinements were made by the project, advisory, and development groups. The PRISMA-IPD Development Group reached agreement on the PRISMA-IPD checklist and flow diagram by consensus. FINDINGS Compared with standard PRISMA, the PRISMA-IPD checklist includes 3 new items that address (1) methods of checking the integrity of the IPD (such as pattern of randomization, data consistency, baseline imbalance, and missing data), (2) reporting any important issues that emerge, and (3) exploring variation (such as whether certain types of individual benefit more from the intervention than others). A further additional item was created by reorganization of standard PRISMA items relating to interpreting results. Wording was modified in 23 items to reflect the IPD approach. CONCLUSIONS AND RELEVANCE PRISMA-IPD provides guidelines for reporting systematic reviews and meta-analyses of IPD.
引用
收藏
页码:1657 / 1665
页数:9
相关论文
共 50 条
  • [1] Compliance of Individual-Participant Data Meta-analyses Published in Stroke with the PRISMA-IPD Statement: A Systematic Review
    Jumah, Fareed
    Ashraf, Omar
    Rallo, Michael S.
    Raju, Bharath
    Chotai, Silky
    Ghadiya, Arjun
    Narayan, Vinayak
    Gupta, Gaurav
    Nanda, Anil
    NEUROSURGERY, 2020, 67 : 125 - 126
  • [2] Compliance With Preferred Reporting Items for Systematic Review and Meta-Analysis Individual Participant Data Statement for Meta-Analyses Published for Stroke Studies
    Jumah, Fareed
    Chotai, Silky
    Ashraf, Omar
    Rallo, Michael S.
    Raju, Bharath
    Gadhiya, Arjun
    Sun, Hai
    Narayan, Vinayak
    Gupta, Gaurav
    Nanda, Anil
    STROKE, 2021, 52 (09) : 2817 - 2826
  • [3] Preferred reporting items for systematic review and meta-analysis protocols (PRISMA-P) 2015 statement
    Moher, David
    Shamseer, Larissa
    Clarke, Mike
    Ghersi, Davina
    Liberati, Alessandro
    Petticrew, Mark
    Shekelle, Paul
    Stewart, Lesley A.
    SYSTEMATIC REVIEWS, 2015, 4
  • [4] Preferred reporting items for systematic review and meta-analysis protocols (PRISMA-P) 2015 statement
    Moher, David
    Shamseer, Larissa
    Clarke, Mike
    Ghersi, Davina
    Liberati, Alessandro
    Petticrew, Mark
    Shekelle, Paul
    Stewart, Lesley A.
    REVISTA ESPANOLA DE NUTRICION HUMANA Y DIETETICA, 2016, 20 (02): : 148 - 160
  • [5] Preferred reporting items for systematic review and meta-analysis protocols (PRISMA-P) 2015 statement
    David Moher
    Larissa Shamseer
    Mike Clarke
    Davina Ghersi
    Alessandro Liberati
    Mark Petticrew
    Paul Shekelle
    Lesley A Stewart
    Systematic Reviews, 4 (1)
  • [6] Preferred reporting items of systematic review and meta-analyses: the PRISMA statement
    Moher, D.
    Liberati, A.
    Tetzlaff, J.
    Altman, D. G.
    DEUTSCHE MEDIZINISCHE WOCHENSCHRIFT, 2011, 136 (15) : E25 - E25
  • [7] Preferred Report Items for systematic reviews and meta-analysis: The PRISMA Statement
    Ziegler, A.
    Antes, G.
    Koenig, I. R.
    DEUTSCHE MEDIZINISCHE WOCHENSCHRIFT, 2011, 136 (08) : E9 - E15
  • [8] Preferred Reporting Items for a Systematic Review and Meta-analysis of Diagnostic Test Accuracy Studies The PRISMA-DTA Statement
    McInnes, Matthew D. F.
    Moher, David
    Thombs, Brett D.
    McGrath, Trevor A.
    Bossuyt, Patrick M.
    JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION, 2018, 319 (04): : 388 - 396
  • [9] Evaluation of the Endorsement of the Preferred Reporting Items for Systematic Reviews and Meta-Analysis (PRISMA) Statement on the Quality of Published Systematic Review and Meta-Analyses
    Panic, Nikola
    Leoncini, Emanuele
    de Belvis, Giulio
    Ricciardi, Walter
    Boccia, Stefania
    PLOS ONE, 2013, 8 (12):
  • [10] Preferred Reporting Items for Systematic Reviews and Meta-Analyses: The PRISMA Statement
    Moher, David
    Liberati, Alessandro
    Tetzlaff, Jennifer
    Altman, Douglas G.
    JOURNAL OF CLINICAL EPIDEMIOLOGY, 2009, 62 (10) : 1006 - 1012